BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10309292)

  • 21. Did FDA jump the gun?
    Archambault GF
    Hosp Formul; 1977 Oct; 12(10):722. PubMed ID: 10305387
    [No Abstract]   [Full Text] [Related]  

  • 22. Patient package inserts: a research perspective.
    Morris LA; Groft SC
    Drug Ther; 1982; ():191-217. PubMed ID: 7105993
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of drugs for unlabeled indications.
    Nightingale SL
    Am Fam Physician; 1986 Sep; 34(3):269. PubMed ID: 3751849
    [No Abstract]   [Full Text] [Related]  

  • 24. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MedGuide: at last a long-sought opportunity for patient education about prescription drugs.
    Marwick C
    JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654
    [No Abstract]   [Full Text] [Related]  

  • 26. The status of unit-of-use in Europe and the United States: an evolution in drug dispensing.
    Archambault GF
    Hosp Formul; 1979 Jan; 14(1):70-1, 75-6, 78-9. PubMed ID: 10297341
    [No Abstract]   [Full Text] [Related]  

  • 27. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational drug use in Cambodia: study of three pilot health centers in Kampong Thom Province.
    Chareonkul C; Khun VL; Boonshuyar C
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):418-24. PubMed ID: 12236445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
    Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
    Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics
    Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug promotion.
    Kalish RS
    N Engl J Med; 1995 Apr; 332(15):1032; author reply 1033. PubMed ID: 7794341
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The patient package insert--health care provider's friend or foe?
    Hirsh HL
    Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
    [No Abstract]   [Full Text] [Related]  

  • 34. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
    Cheng C; Guglielmo BJ
    Arch Intern Med; 2011 May; 171(10):946-7. PubMed ID: 21606102
    [No Abstract]   [Full Text] [Related]  

  • 35. Educating patients about their medications: the potential and limitations of written drug information.
    Shrank WH; Avorn J
    Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing prescription drugs as causes of death on death certificates.
    Wysowski DK; Nourjah P
    Public Health Rep; 2004; 119(6):520. PubMed ID: 15504443
    [No Abstract]   [Full Text] [Related]  

  • 37. Rx package inserts: redesigned with fewer errors in mind.
    Fass JA; Seamon MJ; Cytacki J
    J Fam Pract; 2007 Jun; 56(6):438-41. PubMed ID: 17543253
    [No Abstract]   [Full Text] [Related]  

  • 38. Initial experience with teriparatide in the United States.
    Gold DT; Pantos BS; Masica DN; Misurski DA; Marcus R
    Curr Med Res Opin; 2006 Apr; 22(4):703-8. PubMed ID: 16684431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving prescription drug labeling.
    Wolf MS; Bailey SC
    N C Med J; 2007; 68(5):340-2. PubMed ID: 18183755
    [No Abstract]   [Full Text] [Related]  

  • 40. Look-alike and sound-alike drug names: the problem and the solution.
    Davis NM; Cohen MR; Teplitsky B
    Hosp Pharm; 1992 Feb; 27(2):95-8, 102-5, 108-10. PubMed ID: 10183617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.